Immagina BioTechnology is featured in a Nature Biotechnology article highlighting the growing interest in the dark proteome and the technologies helping researchers uncover previously overlooked proteins.
Seven European RNA companies have launched the European RNA Alliance, creating a shared gateway to RNA technologies, scientific expertise and Made-in-Europe innovation.
September takes the Immagina team across Europe, the US, and Asia for a busy month of RNA, translation, proteomics, and biotechnology events. Meet the team at conferences and research meetings from Newcastle to Singapore.
Discover our RNA Symposium panels! The first panel will explore the future of personalized cancer therapies, while the second will dive into Big Pharma & RNA startups. Inspiring voices from academia, biotech & pharma will drive the discussions.
Meet Kfir Oved, CEO & Founder of Canopy Immuno-Therapeutics, at our RNA Symposium! He’ll present how Antigen-Drug Conjugates (AgDCs) can transform autoimmune disease treatment. Click here to learn more about him!
Juan Pablo Tosar (Institut Pasteur de Montevideo & B4-RNA) joins our RNA symposium with a talk on extracellular nicked tRNAs as biomarkers for liquid biopsy. Click here to learn more about his pioneering research!
This website uses cookies to ensure the best experience possible. More information...